| Literature DB >> 35221986 |
Keqiang He1, Juan Zhang2,3, Wei Zhang1, Sheng Wang1, Dingfeng Li2,3,4, Xiaolin Ma2,3, Xiaofan Wu1, Xiaoqing Chai1, Qiang Liu2,3,5.
Abstract
Perioperative neurocognitive disorders (PNDs) are a type of cognitive dysfunction occurring with a higher incidence in elderly patients. However, the pathological mechanism of PND and effective treatment remain elusive. We generated a PND mouse model by providing wild-type mice with surgical trauma; in our case, we used tibial fracture to investigate PND pathology. Mice aged 7-8 months were randomly divided into two groups: the surgery (tibial fracture) group and the control (sham) group. All mice were subjected to anesthesia. We examined the transcriptome-wide response in the hippocampus, a brain region that is tightly associated with memory formation, of control mice and mice subjected to surgical trauma at day 1 and day 3 after the surgical procedure. We observed reduced transcript levels of respiratory complex components as early as day 1 after surgery, and subsequent protein changes were found at day 3 after surgical trauma. Consequently, the activities of respiratory complexes were reduced, and adenosine triphosphate (ATP) production was decreased in the hippocampus of mice with surgical operations, supporting that respiratory chain function was impaired. In support of these conclusions, the mitochondrial membrane potential (MMP) levels were decreased, and the reactive oxygen species (ROS) levels were significantly increased. Mechanistically, we demonstrated that surgery induced a significant increase in cytokine IL-1β levels at day 1 after surgery, which concomitantly occurred with transcript changes in respiratory complex components. We further uncovered that transcription factors PGC-1α and NRF-1 were responsible for the observed transcript changes in mitochondrial complex components. Importantly, HT22 cells treated with the cytokine IL-1β resulted in similar reductions in PGC-1α and NRF-1, leading to a reduction of both the transcript and protein levels of respiratory complex subunits. Consequently, respiratory function was impaired in HT22 cells treated with IL-1β. Taken together, we demonstrated that reductions in respiratory complex components and subsequent impairment in mitochondrial functions serve as a novel mechanism for PND pathology, providing a potential therapeutic target for PND treatment.Entities:
Keywords: mitochondrial respiratory chain complex; neuroinflammation; perioperative neurocognitive disorders; postoperative cognitive dysfunction; respiratory function
Year: 2022 PMID: 35221986 PMCID: PMC8865419 DOI: 10.3389/fnagi.2022.772066
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
The forward and reverse primers for Quantitative PCR (qPCR) detection.
| Gene | Primers | Sequence (5′ to 3′) |
| Cox5a | Forward primer | GCCGCTGTCTGTTCCATTC |
| Cox5a |
| GCATCAATGTCTGGCTTGTTGAA |
| Ndufs6 | Forward primer | GGGGAAAAGATCACGCATACC |
| Ndufs6 |
| CAAAACGAACCCTCCTGTAGTC |
| Ndufb8 | Forward primer | TGTTGCCGGGGTCATATCCTA |
| Ndufb8 |
| AGCATCGGGTAGTCGCCATA |
| Ndufa1 | Forward primer | ATGTGGTTCGAGATTCTCCCT |
| Ndufa1 |
| TGGTACTGAACACGAGCAACT |
| Cox4i1 | Forward primer | ATTGGCAAGAGAGCCATTTCTAC |
| Cox4i1 |
| CACGCCGATCAGCGTAAGT |
| Ndufa2 | Forward primer | TTGCGTGAGATTCGCGTTCA |
| Ndufa2 |
| ATTCGCGGATCAGAATGGGC |
| Ndufs7 | Forward primer | GTTCATCAGAGTGTAGCCACTG |
| Ndufs7 |
| CAGGCCGAAGGTCATAGGC |
| Atp5d | Forward primer | TGCTTCAGGCGCGTACATAC |
| Atp5d |
| CACTTGCTTGACGTTGGCA |
| Uqcr10 | Forward primer | ATCCCTTCGCGCCTGTACT |
| Uqcr10 |
| GTGCTCGTAGATCGCGTCT |
| Ndufa6 | Forward primer | GGTGAAACAAGGACGGGATA |
| Ndufa6 |
| GGAAAAACCGCATAACGTGT |
| β-actin | Forward primer | GGCTGTATTCCCCTCCATCG |
| β-actin |
| CCAGTTGGTAACAATGCCATGT |
| Cox11 | Forward primer | AATGCTGACGTTCATGCCAG |
| Cox11 |
| ACTGTCCAGCTTCAAACGGT |
| Atp5e | Forward primer | CAGGCTGGACTCAGCTACATC |
| Atp5e |
| CCGAAGTCTTCTCAGCGTTC |
| Atp5k | Forward primer | CGGTTCAGGTCTCTCCACTC |
| Atp5k |
| CCGCCAGTTCTCTCTCAATC |
| Atp6v1f | Forward primer | GACACGGTGACTGGTTTCCT |
| Atp6v1f |
| CGAACCATCTCTGCGATGTA |
| Ndufb10 | Forward primer | TGCCAAGAACCGAACCTACT |
| Ndufb10 |
| TGGCACAGTTCTGCTGGTAG |
| Cox8a | Forward primer | ATGTCTGTCCTGACGCCACT |
| Cox8a |
| CAGGCAGAAGACAACACACG |
| Cox7c | Forward primer | GAGTATCCGGAGGTTCACGA |
| Cox7c |
| TAAAGAAAGGTGCGGCAAAC |
| Cox6a1 | Forward primer | AAGGCCCTCACCTACTTCGT |
| Cox6a1 |
| TTCACATGAGGGTTGTGGAA |
| Uqcr11 | Forward primer | TGCTGAGCAGGTTTCTAGGC |
| Uqcr11 |
| CCTTCTTAAACTTGCCGTTGA |
| Ndufb9 | Forward primer | GCCCGGTTTGAAGAACATAA |
| Ndufb9 |
| GCACCATTCTGGAACCTTGT |
FIGURE 1Evaluation of cognition and neuroinflammation in mice after tibial surgery. (A) Contextual memory was evaluated by the novel object recognition (NOR) task. The recognition index was calculated for control and surgery mice at the training phase and 4 h after the training (n = 12 per group). (B) Contextual memory was evaluated by the fear conditioning task. Freezing time was recorded, and the ratio of freezing time to the total testing time was calculated (n = 12 per group). (C–E) Wild-type (WT) mice were subjected to tibial surgery, and hippocampal tissues were collected at 6 h or 1 day post-surgery. Levels of IL-6 (C) and IL-1β (D) in the hippocampus were determined by an ELISA-based approach (n = 6–9 per group). Levels of IL-1β in the hippocampus were also determined by immunoblotting and densiometric analysis (E) (n = 4 per group). In this and subsequent figures, h represents hours and d represents days. *P < 0.05 by independent samples Student’s t-test; n.s. not significant; error bars denote the standard error of mean (SEM).
FIGURE 2Transcriptome profiles of hippocampal tissues from control mice and mice at 1 day after surgery. (A) Pie chart demonstrating the total number of differentially expressed genes (DEGs) (fold-change cutoff = 1.5) and the number of significantly up- and downregulated genes (surgery vs. control). (B) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis for significantly downregulated genes in (A). (C–E) Biological process (C), molecular function (D), and cellular component (E) from Gene Ontology (GO) analysis for significantly downregulated genes in (A). (F) DEGs in the surgery vs. control groups were visualized in a heatmap. Oxidative phosphorylation-related genes are indicated on the right side of this heatmap.
FIGURE 3Differential expression of oxidative phosphorylation-related genes was visualized in heatmaps and validated by Quantitative PCR (qPCR). (A,B) Genes enriched in the “oxidative phosphorylation” (A) and “Alzheimer’s disease” (B) terms from Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis are visualized in heatmaps. (C) Levels of oxidative phosphorylation-related genes in respiratory chain complexes in control vs. surgery mice were determined by qPCR-based analysis. β-actin was included as an internal control. Data are presented as fold changes in the surgery over controls (n = 8 per group). *P < 0.05; **P < 0.01; ***P < 0.001 by independent samples Student’s t-test; error bars denote the SEM.
FIGURE 4Respiratory complex levels and respiratory function are decreased in the Perioperative neurocognitive disorder (PND) mouse brain by downregulating both peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) and Nuclear respiratory factor-1 (NRF-1) levels. (A,B) Protein levels of Atp5d and Atp5k (complex V); Cox5a (complex IV); and Ndufs6, Ndufb8, and Ndufb10 (complex I) were determined in hippocampal tissues collected from control and surgery mice (1 day post-surgery) (n = 4) (A) or from control and surgery mice (3 days post-surgery) (n = 5) (B), by immunoblotting and densiometric analysis. (C) Levels of PGC-1α and NRF-1 in the hippocampal tissues of control and surgery mice (1 day post-surgery) were determined by immunoblotting and densiometric analysis (n = 6). β-actin was included as an input control. (D,E) Hippocampal tissues were isolated from control or surgery mice (1 day or 3 days post-surgery). Enzymatic activities of NADH dehydrogenase (complex I) (D) and cytochrome C oxidase (complex IV) (E) were assessed by an ELISA-based approach (n = 8 per group). (F–H) Hippocampal tissues were isolated from control or surgery mice (1 day or 3 days post-surgery) (n = 5 per group). (F) Adenosine triphosphate (ATP) levels were assessed by an ELISA-based analysis. (G) Mitochondrial membrane potential (MMP) levels were determined by the JC-1 fluorescence probe-based approach. (H) Relative reactive oxygen species (ROS) levels were determined by the DCFHDA probe-based approach. *P < 0.05; **P < 0.01; ***P < 0.001 by independent samples Student’s t-test; n.s. not significant; error bars denote the SEM.
FIGURE 5HT22 cells treated with interleukin-1β (IL-1β) show reduced respiratory complex levels and decreased mitochondrial respiratory function. (A–F) HT22 cells were treated with IL-1β for 48 h. Levels of selected respiratory chain components were assessed by Quantitative PCR (qPCR) (n = 8 per group) (A) and by immunoblotting and densiometric analysis (B) (n = 4 per group). (C) Representative immunofluorescence images of Ndufs6 (green) and DAPI (blue) in control and IL-1β-treated HT22 cells. Scale bar: 20 μm. Relative immunofluorescence intensity was plotted in IL-1β-treated HT22 cells over control HT22 cells (n = 3 per group). (D) The enzymatic activities of complex I and complex IV were determined by an ELISA-based approach (n = 6 per group). (E) Adenosine triphosphate (ATP) levels were determined in HT22 cells by an ELISA-based analysis. Relative ATP levels were plotted in IL-1β-treated HT22 cells over control HT22 cells (n = 8 per group). (F) Representative images of reactive oxygen species (ROS) (green) in HT22 cells treated with or without IL-1β using a DCFHDA fluorescence probe. Scale bar: 50 μm. Relative immunofluorescence intensity was plotted in IL-1β-treated HT22 cells over control HT22 cells (n = 3 per group). *P < 0.05; **P < 0.01; ***P < 0.001 by independent samples Student’s t-test; error bars denote the SEM.
FIGURE 6IL-1β induces reductions in peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) and Nuclear respiratory factor-1 (NRF-1) levels in HT22 cells. (A,B) Levels of PGC-1α and NRF-1 were determined by quantitative PCR (qPCR) (A) (n = 4) and by immunoblotting and densiometric analysis (B) in control and IL-1β-treated HT22 cells (n = 4 per group). β-actin was included as an input control. (C) Representative images of PGC-1α (green) and DAPI (blue) in control HT22 cells and HT22 cells treated with IL-1β. Scale bar: 20 μm. The relative immunofluorescence intensity of PGC-1α was plotted in IL-1β-treated HT22 cells over control HT22 cells (n = 3 per group). (D) Representative images of NRF-1 (green) and DAPI (blue) in control HT22 cells and HT22 cells treated with IL-1β. Scale bar: 20 μm. Relative immunofluorescence intensity of NRF-1 in IL-1β-treated HT22 cells over control HT22 cells (n = 3 per group). (E) HT22 cells were transfected with control plasmid (control vector) or PGC-1α overexpression plasmid (PGC-1α OE) prior to IL-1β treatment. Levels of PGC-1α, Ndufs6, and Cox5a in HT22 cells with (control vector and PGC-1α OE) or without (control) IL-1β treatment were determined by immunoblotting and densiometric analysis (n = 3). β-actin was included as an input control. *P < 0.05; **P < 0.01; ***P < 0.001 by independent samples Student’s t-test or one-way ANOVA; error bars denote the SEM.